Alfredo
Carrato Mena
Profesor/a Emérito/a
University of Toronto
Toronto, CanadáPublicaciones en colaboración con investigadores/as de University of Toronto (5)
2016
-
HER2 testing and clinical decision making in gastroesophageal adenocarcinoma guideline from the College of American Pathologists, American Society for clinical Pathology, and American Society of Clinical Oncology
American Journal of Clinical Pathology, Vol. 146, Núm. 6, pp. 647-669
-
HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: Guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
Archives of Pathology and Laboratory Medicine, Vol. 140, Núm. 12, pp. 1345-1363
2015
-
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: The GAMMA trial
Annals of Oncology, Vol. 26, Núm. 5, pp. 921-927
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633